The Leukemia and Lymphoma Society (LLS) National Research Registry
ConditionBlood Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21+
SponsorBlood Cancer United
About this trial
The Leukemia and Lymphoma Society (LLS) has built a National Research Registry to evaluate real world experiences and medical outcomes for people with blood cancer, before, during, and after blood cancer treatments.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
People with blood cancer, before, during, and after blood cancer treatments.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
any/all treatments for blood cancer
Other interventionFollowing people undergoing any/all treatments for blood cancer.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
LLS will monitor outcomes of people being treated for blood cancer.
. The LLS National Research Registry will collect data on up to 1000 research subjects, over up to 10 years, storing that data, including protected health information (PHI) and images, in secure databases, and share de-identified summary data with research partners (like academic researchers, advocacy groups, and pharmaceutical companies) that are advancing treatments for blood cancer. Participation in The LLS National Research Registry may not give research subjects any immediate benefit. It is hoped the knowledge gained from data collected in The LLS National Research Registry will benefit people with blood cancers in the future using this information for research purposes, directed at blood cancers and associated comorbidities.
Time frame
10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov